Long Term Efficacy of Deucravacitinib
- Jeremy Visser
- Jul 13, 2023
- 1 min read
Dr. Ronald B. Vender discusses the TYK2 inhibitor deucravacitinib at the World Congress of Dermatology 2023 in Singapore.
top of page
it's where dermatology lives
bottom of page
Comments